Immunoassay drug screening tests are usually used as a control during metha
done maintenance programmes, to check cleanliness of drugs during detoxific
ation treatment and abstinence programmes. False-positive results can have
catastrophic consequences for the patient, as shown in the case report. Fal
se-positive results were reported for opioids following ofloxacin or rifamp
icin and for LSD following mucolytic. Since inpatient and outpatient units
usually employ an urine quick test (immunoassay), positive results should b
e checked with gas chromatography/mass spectroscopy (GC-MS) or high pressur
e liquid chromatography (HPLC) before conclusions from the positive urine s
creening results can be drawn.